Cargando…
Single-Nucleotide Polymorphism–Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis
IMPORTANCE: Few studies have evaluated the association between a single-nucleotide polymorphism–based genetic risk score (GRS) and patient age at prostate cancer (PCa) diagnosis. OBJECTIVES: To test the association between a GRS and patient age at PCa diagnosis and to compare the performance of a GR...
Autores principales: | Na, Rong, Labbate, Craig, Yu, Hongjie, Shi, Zhuqing, Fantus, Richard J., Wang, Chi-Hsiung, Andriole, Gerald L., Isaacs, William B., Zheng, S. Lilly, Helfand, Brian T., Xu, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6991229/ https://www.ncbi.nlm.nih.gov/pubmed/31880795 http://dx.doi.org/10.1001/jamanetworkopen.2019.18145 |
Ejemplares similares
-
Reliability of Ancestry-specific Prostate Cancer Genetic Risk Score in Four Racial and Ethnic Populations
por: Shi, Zhuqing, et al.
Publicado: (2022) -
Genetic Susceptibility for Low Testosterone in Men and Its Implications in Biology and Screening: Data from the UK Biobank
por: Fantus, Richard J., et al.
Publicado: (2021) -
Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank
por: Wei, Jun, et al.
Publicado: (2020) -
Assessing the clinical utility of genetic risk scores for targeted cancer screening
por: Conran, Carly A., et al.
Publicado: (2021) -
Validation of a prostate cancer polygenic risk score
por: Black, Mary H., et al.
Publicado: (2020)